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Controlled hypotensionAbstract Background: Controlled hypotension is a technique that is used to limit intraoperative
blood loss, improve operative ﬁeld, decrease duration of surgery, and thus decrease the amount
of blood transfused.
Objective: The aim of this double-blind, randomized, controlled study is to compare the effects of
sevoﬂurane combined with dexmedetomidine (DEX) or nimodipine (NIMO) on blood loss in the
surgical ﬁeld, recovery time, and patient tolerability in spine surgery.
Methods: Forty-eight (48) patients, 20–50 years of age, ASA I-II, randomly divided into DEX
group (n= 24) and NIMO group (n= 24). In the DEX group, a loading dose of DEX infused over
10 min at a rate of 1 lg/kg/h, followed by a maintenance rate of 0.4–0.8 lg/kg/h. In the NIMO
group, the dose infused at 15 lg/kg/h for 2 h (approximately 1 mg/h). The infusion rates were
titrated to maintain mean arterial pressure (MAP) of 60–65 mm. Hg. We recorded MAP, intraop-
erative blood loss, total recovery time, total fentanyl consumption, incidence of arrhythmia or
ischemia, and postoperative nausea and vomiting.
Results: No signiﬁcant difference in the amount of blood loss between the two groups was
observed. Total fentanyl consumption was signiﬁcantly higher in the NIMO group
(350 ± 8.9 lg) versus (200 ± 5.5 lg) in the DEX group (p= 0.002). Recovery time was shorter
in the NIMO group (6.8 min) versus (8.9 min) in the DEX group (p= 0.001).
Conclusions: Dexmedetomidine and Nimodipine provided effective method of controlled hypoten-
sion limiting the blood loss, and NIMO was associated with signiﬁcantly shorter extubation and
recovery times compared with DEX.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.1. Introduction
Signiﬁcant blood loss during post-traumatic spinal stabiliza-
tion surgery is a major anesthetic challenge that might require
transfusion of whole blood or blood products [1].
Decreasing bleeding is important to maintain patient’s
hemodynamic stability and improve the surgical ﬁeld. In spine
surgery, improving the surgical ﬁeld is especially important
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ical structures. Improving the surgical ﬁeld helps the surgeon
to decrease the operative time, which further decreases bleed-
ing [2].
Various agents have been used to provide controlled hypo-
tension including direct acting vasodilators (sodium nitroprus-
side-nitroglycerin), ganglion-blocking agents, beta adrenergic
blockers (esmolol), calcium channel blockers (nicardipine),
a2-agonists (clonidine–dexmedetomidine), volatile agents,
and magnesium sulfate [3–5].
Unfortunately, the available hypotensive agents are still far
from ideal. Some have myocardial depression like esmolol and
magnesium sulfate, and others have long postanesthetic recov-
ery when used in high concentration like inhalation anesthet-
ics, while tachyphylaxis and cyanide toxicity are potential
side effects of nitroprusside. Moreover, potent hypotensive
agents have their own concentration dependent side effects,
e.g., inhalation anesthetics when used alone require such a high
concentration to achieve a signiﬁcant reduction in bleeding
that hepatic or renal injury might occur.
Ideally, hypotensive agent should be easy to administer, has
a short time to onset, has effects that disappear quickly when
administration is discontinued with rapid elimination without
toxic metabolites, negligible effects on vital organs, and has
predictable and dose-dependent effects [3].
Dexmedetomidine is a highly selective a 2-adrenoceptor
agonist recently introduced to anesthesia practice. Mediated
by its central and peripheral sympathetic action, it has dose-
dependent sedative, anxiolytic, and analgesic action without
respiratory depression [6]. Its easy administration proﬁle, pre-
dictability with anesthetic agents and lack of toxic side effects
while maintaining adequate perfusion of the vital organs,
makes it a near-ideal hypotensive agent. Spinal fusion surgery
for idiopathic scoliosis has been safely undertaken with dex-
medetomidine-controlled hypotension [7]. Moreover, dex-
medetomidine associated peripheral vasoconstriction resulted
in minimal bleeding either with skin incision or intraoperative
[8].
Nimodipine, a 1-4 dihydropyridine derivative, is a calcium
channel blocking agent. It is a highly lipid-soluble nifedipine
analog with ready access to the CNS. It has been used as a pro-
phylactic and therapeutic agent for intracranial hemorrhage
associated with cerebral vasospasm [9]. Unlike dexmedetomi-
dine, its desirable hypotensive effect is rather due to peripheral
vasodilatation.
The aim of this study is to compare the effects of dexmede-
tomidine or nimodipine used for controlled hypotension on the
amount of blood loss in the surgical ﬁeld, recovery time, and
tolerability in adult patients undergoing posterior lumbar
spinal fusion due to traumatic fracture.2. Patients and methods
2.1. Patient selection
This study was done in Qena University Hospital in the time
period from December 2011 to December 2012, the study pro-
tocol was approved by the ethics committee of Qena Faculty of
Medicine, and Written informed consent was taken from every
patient sharing the study or from any legally responsible per-
son. We studied 48 patients aged from 20 to 50 years classiﬁedas American Society of Anesthesiologists (ASAs) physical sta-
tus I-II who were candidate for posterior fusion of the lumbar
spine due to traumatic fracture.
We excluded patients with cardiac disease (hypertension-
arrhythmia-ischemic heart disease – valve lesions), preexisting
coagulation defects, hepatic or renal dysfunction, diabetes mel-
litus, neuromuscular disorder, and seizure disorder; patients
receiving beta blockers, calcium channel blockers, digoxin,
anticoagulants, tricyclic antidepressants, and known allergy
to any of the drugs used in the study.2.2. Anesthesia
In this prospective, randomized, double-blind study, we ran-
domly allocated 48 patients into 2 groups according to a com-
puter-generated allocation numbers table. All patients were
hospitalized at the department of orthopedic surgery, Qena
University Hospital, on the day before surgery and had fasted
for at least 6 h before surgery.
No premedication was given and on arrival to the operating
room, and two cannulae were inserted at different sites on the
same arm (under complete aseptic technique): one (20-G) for
the infusion of dexmedetomidine or nimodipine and the other
(18-G) for the administration of ﬂuids, blood, and other drugs.
A 20-G cannula was inserted into a radial artery near the
wrist joint in the non-dominant hand under complete aseptic
technique for direct measurement of arterial blood pressure
which was recorded continuously.
Patients in both groups received 7 ml/kg of ringer’s solution
before induction of anesthesia and were monitored by the
same system for heart rate (HR) and mean arterial pressure
(MAP) [invasive and noninvasive], 12 lead electrocardiography
(ECG), pulse oximetry (SPO2), urine output, and esophageal
temperature were also monitored (Nihon Khoden monitor).
Normothermia was maintained throughout the procedure with
heating mattress and infusion of warm ﬂuids.
Anesthesia was induced with fentanyl 1 lg/kg and propofol
2 mg/kg IV, while 100% oxygen was administered by mask for
the ﬁrst 3 min of induction, IV atracurium 0.5 mg/kg was used
to facilitate tracheal intubation.
All patients were mechanically ventilated (Ohmeda Aespire
7100 anesthesia machine) with a tidal volume of 6–10 ml/kg,
inspiratory/expiratory ratio of 1:2, and a respiratory rate ad-
justed to maintain end-tidal carbon dioxide (ETCO2) concen-
tration of 30–35 mmHg (10–16 breaths/min).
All patients were placed prone on aRelton Framewith a chest
and pelvic rolls, leaving the abdomen hanging free. All patients
were positioned and operated on by the same surgery team.
General anesthesia was maintained with sevofurane (end-ti-
dal concentration of sevoﬂurane, 1.8–2.5%) in 100% oxygen
and adequate muscle relaxation maintained with incremental
bolus doses of 10 mg atracurium when indicated by the periph-
eral nerve stimulation (TOF guard).
Infusions were initiated with dexmedetomidine or nimodi-
pine to achieve MAP between 60 and 65 mmHg, prior to skin
incision. This was done by an anesthesiologist other than that
who records the results of the study. In the dexmedetomidine
(PRECEDEX, Hospira) group, a loading dose was infused
intravenously over 10 min at 1 lg/kg diluted in 10 ml. 0.9%
normal saline followed by a maintenance infusion rate of
0.4–0.8 lg/kg/h. In the nimodipine (NIMOTOP, BAYER)
Dexmedetomidine versus nimodipine for controlled hypotension during spine surgery 327group, 15 lg/kg/h (equivalent to 5 ml nimodipine infusion
solution per hour) was infused for 2 h and if this dose is well
tolerated and there is no severe drop of blood pressure, the
dose can be increased after the second hour up to 30 lg/kg/h
(equivalent to 10 ml nimodipine infusion solution per hour).
Nimodipine infusion solution was administered using an infu-
sion pump and not mixed with other drugs or added to infu-
sion bottles (1 bottle of 50 ml infusion solution contains
10 mg nimodipine).
Intraoperative ﬂuids administered for all patients included
ringer lactate as a maintenance ﬂuid and normal saline for def-
icits and losses, including packed RBCs transfusion for blood
loss to a transfusion threshold of hemoglobin = 10 gm/dl and
hematocrit of 25–30%.
The intraoperative estimated blood loss (EBL) for each
procedure was calculated by weighing the surgical gauze pads
and measuring the contents of the suction bottle (with adjust-
ment made for the amount of saline irrigation used) by the
same anesthesiologist for all patients who was unaware of
the study details. The hemoglobin (HB) level and the hemato-
crit value (packed RBCs) were obtained on the preoperative
day and ﬁrst postoperative day.
In both groups, signs of inadequate anesthesia (e.g., in-
creases in MAP greater than the target level, movement, tear-
ing, or sweating) were treated with additional I.V. boluses of
fentanyl in a dose of 1 lg/kg and recorded. Nitroglycerine
was infused if these target levels could not be achieved with
the uppermost dose.
Our primary end point was achieving MAP of 60–
65 mmHg before skin incision, while secondary end points in-
cluded; occurrence of tachycardia, the need to use rescue hypo-
tensive agent, and recovery time.
Reﬂex tachycardia was deﬁned as a heart rate (HR), and
more than 15% of baseline (before induction of anesthesia)
for 10 min with urine output > 1 ml/kg/h (to eliminate the
possibility of tachycardia secondary to hypovolemia) was re-
corded and treated by increasing depth of anesthesia.
Infusion of the study drugs and fentanyl was stopped 5 min
before the anticipated end of surgery, and sevoﬂurane was
stopped after skin closure. At the end of surgery, any residual
neuromuscular blockade was reversed with neostigmine and
atropine to achieve a train of four ratio of at least 0.9 (T of
guard). Extubation time and time to total recovery from anes-
thesia were recorded (Modiﬁed Aldrete’s score P9 on a scale
of 0–10). After complete recovery from anesthesia, patients
were transferred to the recovery room.
The two groups were compared with reference to patient’s
characteristics, intraoperative clinical data (operative time, ur-
ine output, crystalloid infusion, estimated blood loss, spinal
levels fused, surgeon satisfaction, occurrence of reﬂex tachy-
cardia, time to restoration of MAP, intraoperative fentanyl
consumption), requirements for additional hypotensive agent
(Nitroglycerine), and postoperative nausea and vomiting were
recorded.
Blood samples were drawn for measuring HB%, Hct value
in the preoperative day and ﬁrst postoperative day, and
blood samples were taken also for measuring blood urea
nitrogen (BUN), serum creatinine, SGOT, and SGPT. Arte-
rial blood gas analysis was used to determine changes in
pH, partial pressure of CO2 (PaCO2), and bicarbonate
ðHCO3 Þ.2.3. Statistical analysis
Data were analyzed using SPSS statistical package version 15.
Results were presented as mean ± (SD), median (Range),
number, and percentage.
Forty-four patients (22 in each group of the study) were cal-
culated based on a preliminary analysis and a desired power of
80% to detect a difference between groups of 20% regarding
the amount of blood loss in the surgical ﬁeld with a signiﬁcant
level of 5%. Thus, we studied 24 patients in each group.
t-tests were used to compare the two groups with respect to
age, weight, intraoperative clinical data (operative time, crys-
talloid administration, urine output, levels fused, time to resto-
ration of MAP, and occurrence of reﬂex tachycardia), HB%
and Hct values, arterial blood gas analysis, and kidney and li-
ver functions. Mann–Whitney test was used to compare the
two groups with respect to estimated blood loss, time to mod-
iﬁed aldrete score >9(min) and intraoperative fentanyl con-
sumption. MAP and HR were compared between the two
groups using unpaired t-test and using paired t-test for com-
parison in each group. Sex, presence of hypotensive agent,
hypotension, bradycardia, nausea, and vomiting were com-
pared in the two groups using Fisher exact test. P value of less
than 0.05 was considered signiﬁcant.
3. Results
WE enrolled 50 patients undergoing posterior lumbar spine fu-
sion. Two patients had been excluded because of hypertension.
Forty-eight patients were divided equally to either the dexmede-
tomidine group (n= 24) or the nimodipine group (n= 24).
There was no statistically signiﬁcant difference between the
two groups with regard to age, sex, weight, or ASA physical
status (Table 1).
There was no statistically signiﬁcant difference between the
two groups with regard to operative time, crystalloid adminis-
tration, urine output, estimated blood loss, and occurrence of
reﬂex tachycardia, while there was a statistically signiﬁcant dif-
ference in the time to restoration of MAP between the two
groups (Table 2).
There was no statistically signiﬁcant difference between the
two groups in MAP (Fig. 1) or HR (Fig. 2) at baseline, after
induction, during the hypotensive period or at the end of sur-
gery, but within each group, MAP and HR during the hypo-
tensive period were signiﬁcantly lower than at baseline after
induction and at the end of the surgery in each group
(P< 0.005).
Mean intraoperative fentanyl consumption was highly sig-
niﬁcant in the nimodipine group compared with the dexmede-
tomidine group (P= 0.002), while the mean time to
extubation was signiﬁcantly shorter in the nimodipine group
than in the dexmedetomidine group (P= 0.001). Similarly,
the time to total recovery from anesthesia (modiﬁed aldrete
score P9) was signiﬁcantly shorter in the nimodipine group
compared with the dexmedetomidine group (P= 0.002)
(Table 3).
During this study, there was no need to use nitroglycerine
as a rescue hypotensive agent.
There was no statistically signiﬁcant difference between the
two groups regarding HB%, Hct value, pH, PaCO2, ðHCO3 Þ,
Table 2 Intraoperative clinical data: values are expressed as
mean ± SD, P 6 0.05.
Dexmedetomidine
group (n= 24)
Nimodipine
group (n= 24)
P value
Operative time (h) 3.9 ± 0.8 4.1 ± 0.9 0.189
Urine output: (cc/kg/h) 2.1 ± 0.3 2.4 ± 0.5 0.275
Crystalloid (cc/kg/h) 10.7 ± 3.9 9.9 ± 2.7 0.398
Estimated blood loss (cc) 385 ± 65 415 ± 78 0.869
Levels fused 2.8 ± 0.4 2.6 ± 0.3 0.754
Time to restoration
of MAP (min.)
11.3 ± 3.2 26.8 ± 4.1 0.05
Occurrence of reﬂex
tachycardia
2/24 3/24
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Figure 1 Perioperative mean arterial pressure (MAP) in both
data are mean ± SD. \P< 0.05 relative to the baseline value.
Dex. Group Nimo. Group
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Figure 2 Perioperative heart rate (HR) in both groups: data are
mean ± SD. \P< 0.05 relative to the baseline value.
Table 3 Hemoglobin and hematocrit values in both groups;
preoperative day and 1st postoperative day: values are
mean ± SD.
Normal
value
Dexmedetomidine
group (n= 24)
Nimodipine
group (n= 24)
P
value
Hemoglobin (gm%)
Preoperative day 13.4 ± 1.6 13.1 ± 1.2 0.563
1st Postoperative
day
13.1 ± 1.4 12.8 ± 1.9 0.657
Hematocrite (%)
Preoperative day 0.39 ± 0.04 0.40 ± 0.04 0.756
1st Postoperative
day
0.35 ± 0.05 0.35 ± 0.05 0.683
Table 1 Demographic characteristics in adults undergoing
spine fusion surgery.
Dexmedetomidine
group (n= 24)
Nimodipine
group (n= 24)
P value
Age (year): mean ± SD 37.8 (± 10.7) 35.9 (± 14.8) 0.117
Sex (number, %)
Female 8 (33.3%) 7 (29.2%)
Male 16 (66.7%) 17 (70.8%)
Weight (kg): mean ± SD 67.1 ± 14.5 68.9 ± 18.1 0.899
ASA physical status:
ASA I 22 (91.7%) 21 (87.5%)
ASA II 2 (8.3%) 3 (12.5%)
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SGPT at preoperative and postoperative periods (Table 4).
4. Discussion
Extensive blood loss during spine surgery leads to greater
transfusion needs and serious consequences of the patient’s
hemodynamic equilibrium and can cause severe neurological
damage because of the vicinity of major and highly fragile neu-
rological structures. In terms of the surgeon, it is important toreduce bleeding to allow a better view of the surgical ﬁeld,
thereby increasing the surgeon’s control and shortening surgi-
cal time which further decreases bleeding (see Table 5).
Controlled hypotension is the most commonly used tech-
nique for reducing blood loss in various types of surgeries,
including spine surgery [10], but it may be associated with in-
creased risk of neurological deﬁcit due to reduced spinal cord
perfusion [11].
The key equation in the provision of deliberate hypotension
is MAP= C.O.P.X S.V.R. So, MAP can be reduced by either
decreasing S.V.R. or C.O.P. or both. Inducing hypotension
only by a reduction in C.O.P. is not feasible because the main-
tenance of tissue blood ﬂow is mandatory. S.V.R. can be re-
duced by peripheral V.D. of the resistance vessels, while
C.O.P. can be reduced by decreasing V.R., H.R., myocardial
contractility or a combination of these.
In our study, dexmedetomidine or nimodipine, when used
in combination with sevoﬂurane, provided a comparable opti-
mal surgical ﬁeld. Both drugs were effective in reaching MAP
of 60–65 mmHg and ensure good surgical ﬁeld. This is the ﬁrst
study to compare the effects of dexmedetomidine or nimodi-
pine combined with sevoﬂurane in providing controlled hypo-
tension during spine fusion surgery.
Both drugs demonstrated similar hemodynamic effects dur-
ing spine fusion surgery. A stable MAP was easily achieved in
both groups using the protocol described. However, the time
Table 4 Fentanyl requirements and recovery characteristics
values are expressed as mean ± SD.
Dexmedetomidine
group (n= 24)
Nimodipine
group (n= 24)
P value
Intraoperative fentanyl
consumption (lg)
200.0 ± 55 350 ± 78* 0.002
Time to extubation (min) 8.9 ± 1.8 6.8 ± 1.3* 0.001
Time to
modiﬁed aldrete
score P9 (min)
7.6 ± 2.1 5.7 ± 1.9* 0.001
Table 5 Arterial blood gas analysis kidney and liver function
tests in both groups; preoperative and postoperative: values are
mean ± SD.
Normal
value
Dexmedetomidine
group (n= 24)
Nimodipine
group (n= 24)
P
value
pH: 7.35–7.45
Pre 7.4 (0.1) 7.4 (0.1) 0.747
Post 7.4 (0.1) 7.4 (0.1) 0.747
PaCO2
(mmHg)
35.0–45.0
Pre 38.7 (5.9) 34.4 (5.9) 0.136
Post 30.3 (5.7) 31.2 (5.8) 0.96
HCO3
(mmol/L)
22–26
Pre 22.6 (3.8) 22.6 (3.8) 0.673
Post 22.6 (2.8) 22.6 (2.8) 0.673
S. creatinine
(mg/dl)
0.8–1.2
Pre 0.8 (0.2) 0.8 (0.2) 0.253
Post 0.8 (0.2) 0.8 (0.3) 0.567
BUN
(mg/dl)
8–20
Pre 12.4 (4.1) 10.4 (3.4) 0.256
Post 12.6 (4.8) 11.0 (3.1) 0.383
SGOT Max 45 IU/L
Pre 19.6 (5.8) 21.7 (9.3) 0.665
Post 19.2 (5.3) 20.9 (7.4) 0.363
SGPT Max 45 IU/L
Pre 20.8 (12.8) 20.3 (8.9) 0.817
Post 19.7 (13.2) 19.8 (10.8) 0.992
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ferent between the two groups, with the nimodipine group
requiring approximately 15 min longer to return to the base-
line blood pressure than the dexmedetomidine group. The dif-
ference in the pharmacokinetics of the two drugs may explain
the difference in time courses of the two drugs. Dexmedetom-
idine is a highly selective alpha-2 (a 2) agonist with a biphasic
half-life time (t1/2) with a distribution (t1/2) of 6 min and ter-
minal elimination (t1/2) of 2 h [12]. On the other hand, Nimo-
dipine is a calcium channel blocker which interferes with the
calcium dependent regulatory mechanism of vascular smooth
muscle tone. Removal of nimodipine would not result in resto-
ration of baseline blood pressure until the drug diffused off the
receptor site. The terminal elimination half-life time (t1/2) of
nimodipine is 3 h [13]. However, gradual return of blood pres-sure may be helpful by preventing excess blood loss in the
immediate postoperative period.
In accordance to our research, Hynynen et al. [13], and
Zhou et al. [14], reported that intraoperative infusion of nimo-
dipine and dexmedetomidine, respectively, maintained hemo-
dynamic stability and was well tolerated.
Regarding the intraoperative clinical data of our study, the
results obtained suggest that the intentional moderate hypo-
tensive general anesthesia is safe and enables good control of
blood loss in young healthy adult patients undergoing elective
spine surgery. All patients should be carefully assessed before
surgery for any contra-indications to hypotensive anesthesia,
and the technique has the advantage to lesser major blood loss,
produce a drier surgical ﬁeld, and decrease operating time.
The precise mechanism by which controlled hypotension
decreases blood loss is still obscure. Some studies have postu-
lated that hypotensive anesthesia (leads to an ischemic ﬁeld)
(i.e., ﬂlocal blood ﬂow) which then causes less blood loss.
But, other studies have measured local blood ﬂow through sci-
entiﬁc measures such as ﬂowmetry [15].
Lee et al. [16] measured blood ﬂow in paraspinal muscles
during spine surgery with two hypotensive drugs, reaching a
similar degree of hypotension. They found widely differing val-
ues for local blood ﬂow, although blood loss did not differ.
This result indicates that blood loss is inﬂuenced by many fac-
tors other than local blood ﬂow such as systemic blood pres-
sure [17] and blood ﬂow in the epidural plexus [18].
In the ﬁeld of spinal fusion surgery, some studies report
that bleeding is essentially venous [1], so blood loss will be
inﬂuenced by factors other than a decrease in art pressure.
Factors other than blood pressure postulated to affect intraop-
erative blood loss include intra-abdominal pressure (related to
prone positioning on the Relton-Hall frame which allow the
abdominal viscera to hang freely, reducing the inferior vena
caval pressure), the number of spinal segments operated on,
body weight, pathological nature of the disease necessitating
surgery, and surgeon’s experiences [1].
In our study, all patients were operated due to traumatic
fractures of the spine on 2 to spinal segments and by the same
surgical team. There was no signiﬁcant difference in weight be-
tween the two groups, and all patients were positioned in the
same way and by the same term. So, the effects of the above
mentioned factors have been obtunded.
The estimated blood loss (EBL) in both groups was much
less than 500 ml. So, these values together with the postopera-
tive HB and Hct values ensured minimal blood loss which did
not necessitate intraoperatively packed RBCs transfusion.
It is not desirable to replace all the blood lost during the
surgery because an adult patient with normal cardiopulmonary
function can compensate for up to 20% loss of circulating
blood volume.
The optimal hematocrit value is determined by the oxygen
carrying capacity of the blood and its ﬂuidity in the absence of
hypoxemia. According to Messmer [19], normovolemic pa-
tients who have normal compensatory mechanisms should be
able to tolerate values as low as 0.27–0.3%. This study showed
that the overall hematocrit value dropped to 0.35% which is
higher than the established tolerable range.
Many studies show a signiﬁcant reduction in the need for
homologous transfusion when moderate hypotensive anesthe-
sia is used [20,21].
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in the dexmedetomidine group compared with the nimodipine
group (P= 0.002). Several studies have demonstrated that
perioperative use of dexmedetomidine was associated with a
signiﬁcant reduction in the consumption of fentanyl in a
dose-dependent manner [22,23]. This could be explained by
the sedative and analgesic sparing effects of dexmedetomidine
through central actions in the locus coeruleus and in the dorsal
horn of spinal cord [24,25]. However, dexmedetomidine was
associated with signiﬁcantly longer times to extubation
(p= 0.001) and to total recovery from anesthesia
(p= 0.001). Similar to our study, Iclal et al. reported that
extubation time was signiﬁcantly longer in patients receiving
dexmedetomidine compared with those receiving esmolol for
controlled hypotension during tympanoplasty [26]. In contra-
diction to our study, Zhou et al. reported that the use of dex-
medetomidine in aged patients with total hip replacement
surgery under general anesthesia resulted in reduction in the
extubation time and waking time after surgery.
Our study showed normal blood gas analysis, liver, and kid-
ney functions, probably because MAP was maintained at
approximately 60 mm. Hg in all patients. Also, the regimen pre-
scribed in both groups for inducing hypotension (whether dex-
medetomidine ornimodipine combined with sevoﬂurane and
fentanyl on request) avoided the use of a single hypotensive
agent with its subsequent dose-related side effects. Degoute
[3] reported that adjuvant treatment for deliberate hypotension
is an ideal technique which can reduce adverse effects of the
individual hypotensive agents by reducing their total doses.
5. Limitations
Our study though has number of limitations. To begin with,
there was no untreated control group, as all patients have to
receive hypotensive agent. Second, we investigated single dose
of hypotensive agent. Third, the difﬁculty of investigating sub-
tle clinical factors, for instance, the proﬁciency of anesthesiol-
ogists or surgeons might mask the nature of a procedure that
would be associated with more bleeding in less skilled hands.
Finally, larger prospective controlled studies are necessary to
ensure deﬁnite conclusions about the comparable effects of
both drugs.
6. Conclusion
Both dexmedetomidine and nimodipine, combined with sevo-
ﬂurane, provided an effective method for achieving a bloodless
surgical ﬁeld with controlled hypotension in these patients
undergoing posterior lumbar spine fusion surgery. Nimodipine
was associated with a comparable intraoperative clinical and
recovery times compared with dexmedetomidine.
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